Literature DB >> 21671134

Novel mitochondria-targeted antioxidants: plastoquinone conjugated with cationic plant alkaloids berberine and palmatine.

Konstantin G Lyamzaev1, Antonina V Pustovidko, Ruben A Simonyan, Tatyana I Rokitskaya, Lidia V Domnina, Olga Yu Ivanova, Inna I Severina, Natalia V Sumbatyan, Galina A Korshunova, Vadim N Tashlitsky, Vitaly A Roginsky, Yuriy N Antonenko, Maxim V Skulachev, Boris V Chernyak, Vladimir P Skulachev.   

Abstract

PURPOSE: To develop effective mitochondria-targeted antioxidants composed entirely of natural constituents.
METHODS: Novel mitochondria-targeted antioxidants were synthesized containing plant electron carrier and antioxidant plastoquinone conjugated by nonyloxycarbonylmethyl residue with berberine or palmatine, penetrating cations of plant origin. These compounds, SkQBerb and SkQPalm, were tested in model planar phospholipid membranes and micelles, liposomes, isolated mitochondria and living cells.
RESULTS: SkQBerb and SkQPalm penetrated across planar bilayer phospholipid membrane in their cationic forms and accumulated in mitochondria isolated or in living human cells in culture. Reduced forms of SkQBerb and SkQPalm as well as C10Berb and C10Palm (SkQBerb and SkQPalm analogs lacking plastoquinol moiety) revealed radical scavenging activity in lipid micelles and liposomes, while oxidized forms were inactive. In isolated mitochondria and in living cells, berberine and palmatine moieties were not reduced, so antioxidant activity of C10Berb and C10Palm was not detected. SkQBerb and SkQPalm inhibited lipid peroxidation in isolated mitochondria at nanomolar concentrations; their prooxidant effect was observed at 1,000 times higher concentrations. In human cell cuture, nanomolar SkQBerb and SkQPalm prevented fragmentation of mitochondria and apoptosis induced by exogenous hydrogen peroxide.
CONCLUSION: This is the first successful attempt to construct mitochondria-targeted antioxidants composed entirely of natural components, namely plastoquinone, nonyl, acetyl and berberine or palmatine residues.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21671134     DOI: 10.1007/s11095-011-0504-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  45 in total

1.  In vitro antioxidant studies on the benzyl tetra isoquinoline alkaloid berberine.

Authors:  Annie Shirwaikar; Arun Shirwaikar; Kuppusamy Rajendran; Isaac Sam Raj Punitha
Journal:  Biol Pharm Bull       Date:  2006-09       Impact factor: 2.233

Review 2.  Targeting mitochondria with organelle-specific compounds: strategies and applications.

Authors:  Lema F Yousif; Kelly M Stewart; Shana O Kelley
Journal:  Chembiochem       Date:  2009-08-17       Impact factor: 3.164

3.  Inhibitory effect of berberine on tert-butyl hydroperoxide-induced oxidative damage in rat liver.

Authors:  Jin-Ming Hwang; Chau-Jong Wang; Feu-Pi Chou; Tsui-Hwa Tseng; Yih-Shou Hsieh; Wea-Lung Lin; Chia-Yih Chu
Journal:  Arch Toxicol       Date:  2002-09-24       Impact factor: 5.153

4.  New-generation Skulachev ions exhibiting nephroprotective and neuroprotective properties.

Authors:  E Y Plotnikov; D N Silachev; A A Chupyrkina; M I Danshina; S S Jankauskas; M A Morosanova; E V Stelmashook; A K Vasileva; E S Goryacheva; Y A Pirogov; N K Isaev; D B Zorov
Journal:  Biochemistry (Mosc)       Date:  2010-02       Impact factor: 2.487

5.  Improved analysis of malondialdehyde in human body fluids.

Authors:  A M Jentzsch; H Bachmann; P Fürst; H K Biesalski
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

6.  Cytotoxic effects of Coptis chinensis and Epimedium sagittatum extracts and their major constituents (berberine, coptisine and icariin) on hepatoma and leukaemia cell growth.

Authors:  Chun-Ching Lin; Lean Teik Ng; Fen-Fang Hsu; Den-En Shieh; Lien-Chai Chiang
Journal:  Clin Exp Pharmacol Physiol       Date:  2004 Jan-Feb       Impact factor: 2.557

7.  Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals.

Authors:  V V Neroev; M M Archipova; L E Bakeeva; A Zh Fursova; E N Grigorian; A Yu Grishanova; E N Iomdina; Zh N Ivashchenko; L A Katargina; I P Khoroshilova-Maslova; O V Kilina; N G Kolosova; E P Kopenkin; S S Korshunov; N A Kovaleva; Yu P Novikova; P P Philippov; D I Pilipenko; O V Robustova; V B Saprunova; I I Senin; M V Skulachev; L F Sotnikova; N A Stefanova; N K Tikhomirova; I V Tsapenko; A I Shchipanova; R A Zinovkin; V P Skulachev
Journal:  Biochemistry (Mosc)       Date:  2008-12       Impact factor: 2.487

8.  Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS- and age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke).

Authors:  L E Bakeeva; I V Barskov; M V Egorov; N K Isaev; V I Kapelko; A V Kazachenko; V I Kirpatovsky; S V Kozlovsky; V L Lakomkin; S B Levina; O I Pisarenko; E Y Plotnikov; V B Saprunova; L I Serebryakova; M V Skulachev; E V Stelmashook; I M Studneva; O V Tskitishvili; A K Vasilyeva; I V Victorov; D B Zorov; V P Skulachev
Journal:  Biochemistry (Mosc)       Date:  2008-12       Impact factor: 2.487

9.  Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes.

Authors:  D B Zorov; C R Filburn; L O Klotz; J L Zweier; S J Sollott
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

10.  Protective effects of mitochondria-targeted antioxidant SkQ in aqueous and lipid membrane environments.

Authors:  Y N Antonenko; V A Roginsky; A A Pashkovskaya; T I Rokitskaya; E A Kotova; A A Zaspa; B V Chernyak; V P Skulachev
Journal:  J Membr Biol       Date:  2008-05-21       Impact factor: 1.843

View more
  10 in total

1.  Mitochondria targeting of non-peroxidizable triphenylphosphonium conjugated oleic acid protects mouse embryonic cells against apoptosis: role of cardiolipin remodeling.

Authors:  Yulia Y Tyurina; Muhammad A Tungekar; Mi-Yeon Jung; Vladimir A Tyurin; Joel S Greenberger; Detcho A Stoyanovsky; Valerian E Kagan
Journal:  FEBS Lett       Date:  2011-12-28       Impact factor: 4.124

Review 2.  Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies.

Authors:  Stanley M H Chan; Stavros Selemidis; Steven Bozinovski; Ross Vlahos
Journal:  Pharmacol Ther       Date:  2019-02-26       Impact factor: 12.310

Review 3.  New and revisited approaches to preserving the reperfused myocardium.

Authors:  Robert A Kloner; David A Brown; Marie Csete; Wangde Dai; James M Downey; Roberta A Gottlieb; Sharon L Hale; Jianru Shi
Journal:  Nat Rev Cardiol       Date:  2017-07-27       Impact factor: 32.419

Review 4.  Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies.

Authors:  Olesya Ilkun; Sihem Boudina
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

5.  Mitochondrially targeted nitro-linoleate: a new tool for the study of cardioprotection.

Authors:  Sergiy M Nadtochiy; Jerry Madukwe; Fred Hagen; Paul S Brookes
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

6.  A mitochondrial-targeted coenzyme q analog prevents weight gain and ameliorates hepatic dysfunction in high-fat-fed mice.

Authors:  Brian D Fink; Judith A Herlein; Deng Fu Guo; Chaitanya Kulkarni; Benjamin J Weidemann; Liping Yu; Justin L Grobe; Kamal Rahmouni; Robert J Kerns; William I Sivitz
Journal:  J Pharmacol Exp Ther       Date:  2014-10-09       Impact factor: 4.030

7.  Weak C-H···X (X = O, N) hydrogen bonds in the crystal structure of dihydroberberine.

Authors:  Subramanya Pingali; James P Donahue; Florastina Payton-Stewart
Journal:  Acta Crystallogr C Struct Chem       Date:  2014-03-11       Impact factor: 1.172

Review 8.  Expert consensus document: Mitochondrial function as a therapeutic target in heart failure.

Authors:  David A Brown; Justin B Perry; Mitchell E Allen; Hani N Sabbah; Brian L Stauffer; Saame Raza Shaikh; John G F Cleland; Wilson S Colucci; Javed Butler; Adriaan A Voors; Stefan D Anker; Bertram Pitt; Burkert Pieske; Gerasimos Filippatos; Stephen J Greene; Mihai Gheorghiade
Journal:  Nat Rev Cardiol       Date:  2016-12-22       Impact factor: 32.419

Review 9.  Rhizoma Coptidis and Berberine as a Natural Drug to Combat Aging and Aging-Related Diseases via Anti-Oxidation and AMPK Activation.

Authors:  Zhifang Xu; Wei Feng; Qian Shen; Nannan Yu; Kun Yu; Shenjun Wang; Zhigang Chen; Seiji Shioda; Yi Guo
Journal:  Aging Dis       Date:  2017-12-01       Impact factor: 6.745

10.  Integrated metabolomics and transcriptomics study of traditional herb Astragalus membranaceus Bge. var. mongolicus (Bge.) Hsiao reveals global metabolic profile and novel phytochemical ingredients.

Authors:  Xueting Wu; Xuetong Li; Wei Wang; Yuanhong Shan; Cuiting Wang; Mulan Zhu; Qiong La; Yang Zhong; Ye Xu; Peng Nan; Xuan Li
Journal:  BMC Genomics       Date:  2020-11-18       Impact factor: 3.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.